Majeti; Bharat

Patent Applications and Registrations

Patent applications and USPTO patent grants for Majeti; Bharat.The latest application filed is for "methods and compositions for treating malignant tumors associated with kras mutation".

Company Profile

7.10.18

Majeti; Bharat - San Diego CA
Majeti; Bharat - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Treating Malignant Tumors Associated With Kras Mutation App 20220275373 - Minomi; Kenjirou ; et al.	2022-09-01
Fusogenic compounds for delivery of biologically active molecules Grant 11,413,243 - Tsang , et al. August 16, 2	2022-08-16
Ionizable Compounds And Compositions And Uses Thereof App 20220242820 - Adami; Roger ; et al.	2022-08-04
Fusogenic Compounds For Delivery Of Biologically Active Molecules App 20220233445 - Tsang; Kwok Yin ; et al.	2022-07-28
Ionizable compounds and compositions and uses thereof Grant 11,384,051 - Adami , et al. July 12, 2	2022-07-12
Fusogenic compounds for delivery of biologically active molecules Grant 11,364,200 - Tsang , et al. June 21, 2	2022-06-21
Methods and compositions for treating malignant tumors associated with KRAS mutation Grant 11,352,628 - Minomi , et al. June 7, 2	2022-06-07
Fusogenic compounds for delivery of biologically active molecules Grant 11,318,099 - Tsang , et al. May 3, 2	2022-05-03
Rna Interference Compositions And Methods For Malignant Tumors App 20220087531 - Niitsu; Yoshiro ; et al.	2022-03-24
dsRNA Directed to Coronavirus Proteins App 20220049251 - Harborth; Jens ; et al.	2022-02-17
RNA interference compositions and methods for malignant tumors Grant RE48,887 - Niitsu , et al. January 11, 2	2022-01-11
Methods and compositions for treating malignant tumors associated with kras mutation Grant 10,792,299 - Minomi , et al. October 6, 2	2020-10-06
Rna Interference Delivery Formulation And Methods For Malignant Tumors App 20200157540 - Majeti; Bharat ; et al.	2020-05-21
Methods And Compositions For Treating Malignant Tumors Associated With Kras Mutation App 20190367926 - Minomi; Kenjirou ; et al.	2019-12-05
Fusogenic Compounds For Delivery Of Biologically Active Molecules App 20190133948 - Tsang; Kwok ; et al.	2019-05-09
Ionizable Compounds And Compositions And Uses Thereof App 20190127318 - Adami; Roger ; et al.	2019-05-02
Ionizable compounds and compositions and uses thereof Grant 10,167,253 - Adami , et al. J	2019-01-01
Rna Interference Therapeutics Against Ebola Virus App 20180235995 - Ying; Wenbin ; et al.	2018-08-23
Methods And Compositions For Treating Malignant Tumors Associated With Kras Mutation App 20180002702 - Minomi; Kenjirou ; et al.	2018-01-04
RNA interference compositions and methods for malignant tumors Grant 9,771,582 - Niitsu , et al. September 26, 2	2017-09-26
Methods For Malignant Tumors With Rnai Molecules Targeted To Hsp47 App 20170218365 - Yoneda; Akihiro ; et al.	2017-08-03
Methods And Compositions For Treating Malignant Tumors Associated With Kras Mutation App 20170165289 - Minomi; Kenjirou ; et al.	2017-06-15
Methods and compositions for treating malignant tumors associated with KRAS mutation Grant 9,580,710 - Minomi , et al. February 28, 2	2017-02-28
Ionizable Compounds And Compositions And Uses Thereof App 20160376229 - Adami; Roger ; et al.	2016-12-29
Therapeutic Compositions And Methods For Malignant Tumors With Rnai Molecules Targeted To Hsp47 And P21 App 20160215286 - Niitsu; Yoshiro ; et al.	2016-07-28
Methods And Compositions For Treating Malignant Tumors Associated With Kras Mutation App 20160186183 - Niitsu; Yoshiro ; et al.	2016-06-30
Rna Interference Compositions And Methods For Malignant Tumors App 20160186182 - Niitsu; Yoshiro ; et al.	2016-06-30
Composite Nanostructures And Methods For Making And Using Them App 20120021036 - Majeti; Bharat ; et al.	2012-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.